Elthera Announces Positive Preclinical Proof of Concept (POC) Studies and Start of New Financing SCHLIEREN, Switzerland, March 19, 2018 ---Elthera is pleased to announce that it has demonstrated efficacy of its proprietary antibodies in tumor bearing animals. Anne Schmidt, Elthera CEO said, “We are very encouraged by these results demonstrating [...]